| A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with … M Anttinen, O Ettala, S Malaspina, I Jambor, M Sandell, S Kajander, ... European urology oncology 4 (4), 635-644, 2021 | 79 | 2021 |
| Histopathological evidence for an association of inflammation with ductal pin‐like lesions but not with ductal adenocarcinoma in the prostate of the noble rat J Bernoulli, E Yatkin, A Laakso, M Anttinen, M Bosland, K Vega, ... The Prostate 68 (7), 728-739, 2008 | 43 | 2008 |
| Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer S Malaspina, M Anttinen, P Taimen, I Jambor, M Sandell, I Rinta-Kiikka, ... European Journal of Nuclear Medicine and Molecular Imaging 48, 2951-2959, 2021 | 42 | 2021 |
| Feasibility of MRI-guided transurethral ultrasound for lesion-targeted ablation of prostate cancer M Anttinen, P Mäkelä, V Suomi, A Kiviniemi, J Saunavaara, T Sainio, ... Scandinavian Journal of Urology 53 (5), 295-302, 2019 | 30 | 2019 |
| Neoadjuvant chemotherapy does not increase the morbidity of radical cystectomy: a 10-year retrospective nationwide study AP Salminen, I Koskinen, IM Perez, S Hurme, TJ Murtola, MH Vaarala, ... European urology oncology 1 (6), 525-530, 2018 | 26 | 2018 |
| Salvage magnetic resonance imaging–guided transurethral ultrasound ablation for localized radiorecurrent prostate cancer: 12-month functional and oncological results M Anttinen, P Mäkelä, A Viitala, P Nurminen, V Suomi, T Sainio, ... European Urology Open Science 22, 79-87, 2020 | 18 | 2020 |
| Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12‐month clinical outcomes of a phase I study A Viitala, M Anttinen, C Wright, I Virtanen, P Mäkelä, T Hovinen, T Sainio, ... BJU international 129 (2), 208-216, 2022 | 10 | 2022 |
| Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer M Anttinen, P Mäkelä, P Nurminen, E Yli-Pietilä, V Suomi, T Sainio, ... Scandinavian Journal of Urology 54 (6), 481-486, 2020 | 9 | 2020 |
| Histopathological evaluation of prostate specimens after thermal ablation may be confounded by the presence of thermally-fixed cells M Anttinen, E Yli-Pietilä, V Suomi, P Mäkelä, T Sainio, J Saunavaara, ... International Journal of Hyperthermia 36 (1), 914-924, 2019 | 9 | 2019 |
| Transurethral ultrasound therapy of the prostate in the presence of calcifications: A simulation study V Suomi, B Treeby, J Jaros, P Makela, M Anttinen, J Saunavaara, T Sainio, ... Medical physics 45 (11), 4793-4805, 2018 | 9 | 2018 |
| Acute and subacute prostate MRI findings after MRI-guided transurethral ultrasound ablation of prostate cancer P Mäkelä, M Anttinen, V Suomi, A Steiner, J Saunavaara, T Sainio, ... Acta Radiologica 62 (12), 1687-1695, 2021 | 7 | 2021 |
| New method of using a convolutional neural network for 2D intraprostatic tumor segmentation from PET images O Rainio, J Lahti, M Anttinen, O Ettala, M Seppänen, P Boström, ... Research on biomedical engineering 39 (4), 905-913, 2023 | 4 | 2023 |
| Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers P Mäkelä, C Wright, M Anttinen, PJ Boström, R Blanco Sequeiros Acta Radiologica 64 (3), 1228-1237, 2023 | 3 | 2023 |
| Scarpa fascia preservation to reduce seroma rate on massive weight loss patients undergoing abdominoplasty: a comparative study O Repo, CM Oranges, PG di Summa, P Uusalo, M Anttinen, S Giordano Journal of Clinical Medicine 12 (2), 636, 2023 | 3 | 2023 |
| Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer S Arvola, M Seppänen, S Malaspina, S Mätzke, J Raiko, KL Timonen, ... Nuclear Medicine Communications 43 (5), 510-517, 2022 | 3 | 2022 |
| Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy C Wright, P Mäkelä, A Bigot, M Anttinen, PJ Boström, R Blanco Sequeiros Biomedical Engineering Letters 13 (1), 31-40, 2023 | 2 | 2023 |
| Detection of prostate cancer bone metastases with fast whole-body 99mTc-HMDP SPECT/CT using a general-purpose CZT system S Arvola, M Seppänen, KL Timonen, P Rautio, O Ettala, M Anttinen, ... EJNMMI physics 9 (1), 85, 2022 | 2 | 2022 |
| Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques M Anttinen, R Blanco Sequeiros, PJ Boström, P Taimen Frontiers in Oncology 12, 1043688, 2022 | 2 | 2022 |
| Optimal strategies for managing prostate-specific antigen recurrence after primary radiotherapy in prostate cancer: the Finnish perspective H Seikkula, L Mäkelä, H Visapää, M Anttinen European Urology Focus 9 (5), 698-700, 2023 | 1 | 2023 |
| How should lesions without anatomical correspondence in 18F-PSMA-1007 PET/CT be interpreted-a PROSTAGE follow-up study O Ettala, M Anttinen, T Tommila, S Malaspina, J Kemppainen, ... European Urology 83, S158, 2023 | 1 | 2023 |
